MedTrace Logo

World Trade Center (WTC) CHEST

NCT01466218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1012

Last updated 2014-07-01

No results posted yet for this study

Summary

This project will evaluate the effects of World Trade Center (WTC) exposure in WTC responders 10-13 years following the events of 9/11. Prior studies have described persistent pulmonary function abnormalities in a significant portion of responders. The investigators study seeks to examine the relationship between pulmonary function abnormalities and other markers of chronic cardiopulmonary disease and further elucidate the pathophysiologic effects of exposure to inhaled particulate matter (PM) on 9/11. This study will provide critical information regarding risk of exposure to PM, risk factors for disease and potential for improvements in diagnosis and treatment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Mary Ann McLaughlin, MD, MPH · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466218 on ClinicalTrials.gov